Get started

VOLUMEBREAKOUT

Supreme Petrochem break out and pull back1. Buy or Sell at your own risk 2. Don't risk more than 1%-2% of your capital as stop loss 3. Position Size formula:- Stop Loss/(Buy Price-Initial Stop Loss Price) 4. Sell on initial stop loss hit or close below daily supertrend (for short term traders) or close below weekly supertrend (for long term investors) 5. Some other ways to sell stocks can be a. 25% or 50% up in three weeks or less b. Largest weekly price spread c. Exhaustion gaps d. Heavy daily volume without further upside e. Largest one day price drop With TTM sales growth 86% and TTM profit growth 148%, NSE:SUPPETRO gave a volume breakout after a consolidation since may'21 and pulled back towards the buy zone. Buy if it crosses Rs.864 with a stop loss at Rs.800. Other fundamentals: - 1. SPL has over 50% market share in the polystyrene segment. It is the only domestic manufacturer of extruded PS foam board and styrene methyl methacrylate giving it a strong market position. 2. The Co incurred a total expenditure of 26 crores on ongoing projects related to PS and EPS at Amdoshi and Manali plants during FY21. In FY22, the Co has planned capital expenditure of 260 crores for Speciality Polymers & Compound and hardware replacement at both its plant locations. These projects will add 90,000 MTA of PS and 30,000 MTA of EPS capacity. 3. During FY21, LG Polymers India Ltd's, second largest polystyrene (PS) manufacturer in India Had to shut down its facility post a styrene vapour leakage incident at its Vizag plant. This resulted in more than 30% volume growth for SPL on account of the diversion of the incremental volumes catered by LG Polymers. 4. SPL plans to enter the mass acrylonitrile butadiene styrene (ABS) market, with an initial capacity of around 60,000 tpa to 80,000 tpa by setting up a new line at the existing plant over FY22-FY24. 5. Current Ratio at 2.26 (greater than 1.5 is good), Debt to Equity at 0.03 (less than 0.5 is good) and Interest Coverage at 147 (greater than 3 is good) 6. FCF to CFO at 78.2% (company won't need to borrow for capex in future) 7. Dividend yield at 1.82% (consistent dividend payer since 2010) 8. FII stack increased from 0.74 in September 2020 to 2.07 in December 2021
SLong
by akashbothra
TTK Healthcare break out 1. Buy or Sell at your own risk 2. Don't risk more than 1%-2% of your capital as stop loss 3. Position Size formula:- Stop Loss/(Buy Price-Initial Stop Loss Price) 4. Sell on initial stop loss hit or close below daily supertrend (for short term traders) or close below weekly supertrend (for long term investors) 5. Some other ways to sell stocks can be a. 25% or 50% up in three weeks or less b. Largest weekly price spread c. Exhaustion gaps d. Heavy daily volume without further upside e. Largest one day price drop after a quarter sales growth of 18%, quarter profit growth of 58%, TTM sales growth of 30% and TTM profit growth off 39%, NSE:TTKHLTCARE has given a high-volume breakout today after a consolidation since July 2021. One can buy with a stop at Rs. 798. Other fundamentals: - 1. TTK Healthcare Ltd is engaged in the business of Pharmaceuticals, Consumer Products, Medical Devices, Protective Devices and Foods. It is a part of TT Krishnamachari group; whose flagship company, TTK Prestige Ltd is one of the leading kitchen appliances company in India. 2. The company's pharmaceuticals business include products for both human and veterinary use :- a. Ethical Products/ Pharma Division - The company's ethical pharma business deals in pharmaceutical formulations both herbal and allopathic, in various therapeutic segments and food supplements. It has a network of 1000+ sales team and a network of 3000+ distributors. b. Animal Welfare Division - The company sells a wide range of animal pharma products under this division. Its portfolio includes feed supplements, fertility inducers, antibiotics, cocktail enzymes, etc. Its network is spread over 9,000 veterinarians across India. 3. The company's consumer products business comprises of marketing and distribution of Woodward's Gripewater, EVA range of cosmetics, Good home range of scrubbers, air freshners, etc. The company's brand 'Woodward's Gripe Water' is one of the oldest FMCG brands worldwide and is a market leader in the Indian colic market. It has been marketed in India since 1928. Its distribution network includes 27 warehouses, 2,600+ distributors, 650+ frontline sales team and a reach to 4 lakh+ outlets across India. 4. The company is one of the largest manufacturers of extruded products (papad) in India which are B2B and export customers and are also marketed in selected markets in India. It sells its products under the brand name 'Fryums'. 5. Company is one of the key players in the Indian Condom Industry. It is involved in manufacture and marketing of male contraceptives and other allied products. It sells products under its own brand 'SKORE'. 6. The company's medical devices business is divided into 2 divisions :- a. Orthopedics Division- The company's orthopedics division offers joint replacement portfolio which includes a variety of components, types and sizes. It has technical collaborations with various companies situated in USA, Germany, UK & Italy for the orthopedics business. b. Heart Valve Division - The division manufactures and distributes heart valve prosthesis in India. It manufactures all 3 components for heart valve i.e. Frame, Disc & sewing ring. It has a manufacturing capacity of 20,000 heart valves p.a. 7. Presently, the company owns and operates 8 manufacturing facilities in India in Karnataka, Tamil Nadu, Puducherry, Kerala, and Rajasthan. It has adopted an outsourcing model for manufacturing most of its products, except for foods, medical and protective devices divisions. 8. Promoter Holding at 75% (greater than 45% is good) 9. Dividend Yield at 0.67% (consistent dividend payer since 2010) 10. Debt to equity at 0.02 (less than 1 is good), Interest Coverage at 17.3 (greater than 3 is good), Current ratio at 1.99% (greater than 1.5 is good), FCF to CFO at 59% (company won’t have to raise debt for expansion)
NSE:TTKHLTCARELong
by akashbothra
Jasch is keeping the fight aliveWith quarterly sales increasing by 42% and quarterly profit increasing by 68%, BSE:JASCH posted good set of numbers. This share gave breakout on 2nd Feb and was a buy with a stop at or below Rs.150. Within these volatile markets this share is coming back to it's buy zone again and again and trying to move up. It's still a buy with the same stop loss. Other Fundamentals: - 1. Average ROE for last 5 years above 15% 2. TTM sales growth at 72% and TTM profit growth at 136% 3. Borrowings came down from Rs .23cr to Rs .3cr since Mar'19 4. Debt to equity at 0.04, Interest coverage ratio at 47.9 and ROCE at 24% 5. During FY21, the Co was able to improve the drying speed of PVC coated fabrics in its existing ovens, as a result of which the installed capacity of PVC coated fabrics being manufactured has increased from 78 lakh metres to 94 lakh metres p.a. 6. Some of the major clients of the co include Puma, Red Tape, Bata, Mahindra, Walmart, Calvin Klein etc. 7. The company has recently modified its production lines, which has resulted in development of some new products with significant saving in power and fuel. The company has been concentrating on PU resin and PU Synthetic Leather where the competition is less.
JLong
by akashbothra